NO955347D0 - Hormonal agent for the therapy of acne and its use - Google Patents

Hormonal agent for the therapy of acne and its use

Info

Publication number
NO955347D0
NO955347D0 NO955347A NO955347A NO955347D0 NO 955347 D0 NO955347 D0 NO 955347D0 NO 955347 A NO955347 A NO 955347A NO 955347 A NO955347 A NO 955347A NO 955347 D0 NO955347 D0 NO 955347D0
Authority
NO
Norway
Prior art keywords
hormonal
hormone
daily units
component
hormone component
Prior art date
Application number
NO955347A
Other languages
Norwegian (no)
Other versions
NO308586B1 (en
NO955347L (en
Inventor
Marika Ehrich
Herbert Kuhl
Original Assignee
Marika Ehrich
Herbert Kuhl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955347(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marika Ehrich, Herbert Kuhl filed Critical Marika Ehrich
Publication of NO955347D0 publication Critical patent/NO955347D0/en
Publication of NO955347L publication Critical patent/NO955347L/en
Publication of NO308586B1 publication Critical patent/NO308586B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A hormonal agent for the treatment of acne with two spatially separated hormonal components fitted separately in a packaging unit and intended for administration sequentially in time, consisting of a number of hormonal daily units arranged spatially separately in and individually removable from the packaging unit, a first hormonal component essentially containing as the hormonal active agent only an oestrogen preparation causing an increase in the sex hormone-binding globulin (SHBG) and the second hormone component containing an oestrogen and an anti-androgen preparation in combination, characterized in that the total number of daily units is equal to the total number of days in the desired cycle, in that the first hormone component comprises 5 to 14 and the second hormone component 23 to 14 daily units, and in that the number of daily units of the first hormone component is smaller than that of the second hormone component. The invention also concerns the use of this hormonal agent.
NO955347A 1993-07-01 1995-12-29 Use of a hormonal agent in the manufacture of a composition for the treatment of acne NO308586B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4321957A DE4321957C2 (en) 1993-07-01 1993-07-01 Use of a hormonal agent to treat acne
PCT/DE1994/000629 WO1995001180A1 (en) 1993-07-01 1994-06-03 Hormonal agent for the treatment of acne and its use

Publications (3)

Publication Number Publication Date
NO955347D0 true NO955347D0 (en) 1995-12-29
NO955347L NO955347L (en) 1995-12-29
NO308586B1 NO308586B1 (en) 2000-10-02

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955347A NO308586B1 (en) 1993-07-01 1995-12-29 Use of a hormonal agent in the manufacture of a composition for the treatment of acne

Country Status (14)

Country Link
EP (1) EP0710111B1 (en)
JP (1) JPH09500112A (en)
AT (1) ATE205716T1 (en)
AU (1) AU695894B2 (en)
BR (1) BR9407340A (en)
CA (1) CA2166121A1 (en)
DE (2) DE4321957C2 (en)
DK (1) DK0710111T3 (en)
ES (1) ES2164103T3 (en)
HU (1) HUT73234A (en)
NO (1) NO308586B1 (en)
PT (1) PT710111E (en)
UA (1) UA43337C2 (en)
WO (1) WO1995001180A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (en) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonal agent for the treatment of the skin
US6569845B1 (en) * 1997-12-26 2003-05-27 Mochida Pharmaceutical Co., Ltd. Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026671A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Dosage form for hormonal contraception
DE102004026679A1 (en) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102004026670A1 (en) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102006003508A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Use of hormone combination of estrogen from ethinyl estradiol and metabolites of chlormadinone acetate, with chlormadione acetate as gestagen components, for producing medicament e.g. for preventing menstruation cycle-dependent mood
DE102006003509A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Drug delivery system, for hormonal contraception, comprises hormone-containing daily unit, which exhibits estrogen from ethinyl estradiol and estradiol and from metabolite of the chlormadinone acetate optionally with gestagen component

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU565915B2 (en) * 1982-12-31 1987-10-01 Mortimer, C.H. Pharmaceutical composition of antibiotic and anti- androgen
DE3442857A1 (en) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Composition for the treatment of androgenisation symptoms in women
DE3916112A1 (en) * 1989-05-16 1990-11-22 Schering Ag DIHYDROSPIRORENONE AS AN ANTIANDROGEN
DE4104385C1 (en) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
AU6840894A (en) 1995-01-24
NO308586B1 (en) 2000-10-02
EP0710111B1 (en) 2001-09-19
ES2164103T3 (en) 2002-02-16
JPH09500112A (en) 1997-01-07
DE59409869D1 (en) 2001-10-25
AU695894B2 (en) 1998-08-27
NO955347L (en) 1995-12-29
WO1995001180A1 (en) 1995-01-12
BR9407340A (en) 1996-10-08
DE4321957C2 (en) 1995-09-28
DK0710111T3 (en) 2001-12-10
HUT73234A (en) 1996-07-29
ATE205716T1 (en) 2001-10-15
HU9503770D0 (en) 1996-02-28
CA2166121A1 (en) 1995-01-12
UA43337C2 (en) 2001-12-17
DE4321957A1 (en) 1995-01-12
EP0710111A1 (en) 1996-05-08
PT710111E (en) 2002-02-28

Similar Documents

Publication Publication Date Title
BR9408513A (en) Agent and method for hormonal contraception and / or for the treatment of acne
ES2140658T3 (en) TRANSDERMIC THERAPEUTIC SYSTEMS CONTAINING SEXUAL STEROIDS.
ATE296612T1 (en) ACTIVE INGREDIENTS FOR THE TREATMENT OF SENIL XEROSIS AND PREPARATIONS
AU1255002A (en) Delayed-release pharmaceutical formulations
MY106938A (en) Method of treating premature ejaculation using sertraline
DE68912195D1 (en) Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis.
NO955347L (en) Hormonal agent for the therapy of acne and its use
ATE237331T1 (en) DEUTERATED ACTIVE INGREDIENTS IN TRANSDERMAL APPLICATION
DK0714304T3 (en) Therapeutic system for the treatment of psoriasis
ES2100680T3 (en) COMPOSITION FOR HAIR TREATMENT.
YU56702A (en) Use of fsh for treating infertility
HUP0100542A2 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
KR970705397A (en) ESTROGENS AND PARATHYROID HORMONE FOR TREATING OSTEOPOROSIS
ATE169819T1 (en) (-)-METRIFONATE CONTAINING MEDICINAL PRODUCT
MX9709684A (en) Use of vitamin d4 derivatives for treating skin disorders.
UA19504A (en) Agent for treatment of the skin and hypodermic cellular tissue purulent inflammations
KR970005296A (en) Tonsillitis Treatment
MX9605916A (en) Bio-aromatic compounds carrying an adamantile group in para, pharmaceutical and cosmetic compositions containing them, and uses.
RU95100512A (en) OINTMENT FOR TREATMENT OF SKIN DISEASES
MX9800697A (en) Use of calendula glycosides for the treatment of psoriasis.